ISB News

New Publication in Cell Systems

April 25, 2017

A Cell-Surface Membrane Protein Signature for Glioblastoma

3 bullets:

  • Using integrated protein and gene expression data, ISB researchers developed a 33-gene signature for glioblastoma, an aggressive form of brain cancer.
  • Glioblastoma gene signatures are associated with TGF-b signaling and cancer invasion.
  • Researchers think that some of the glioblastoma gene signatures have the potential to be used as blood biomarkers for this aggressive cancer.

Read the full summary…

Related Articles

  • ISB's Dr. Sui Huang Earns Funding to Tackle Cancer's Biggest Questions

    ISB’s Professor Sui Huang, MD, PhD, has been announced by Cancer Research UK as a member of a global research team funded through its Grand Challenge competition — an international funding initiative that aims to answer some of the biggest questions facing cancer research.

    Read More
  • ISB President Dr. Jim Heath

    ISB President Dr. Jim Heath Awarded $750,000 from Andy Hill Cancer Research Endowment

    The Andy Hill Cancer Research Endowment (CARE) announced $750,000 in grant funding for Dr. Jim Heath’s work on proactive cancer immunotherapies for initial and recurrent disease. This is the first stage of a planned longer program led by Jim and ISB, and involving Swedish Cancer Institute, Earl A. Chiles Research Institute in Portland, and UW Medicine.

    Read More
  • Dr. Sui Huang

    New Principle for Eradicating Cancer: Leave No Dead Cells Behind

    Dead cells, or cell debris, generated by treatments intended to eradicate tumor cells actually act as strong stimulators of tumor progression. The findings of ISB cancer biologist Sui Huang, his former mentee and longtime collaborator Dipak Panigrahy at Beth Isreal Deaconess Medical Center in Boston, and colleagues at Harvard Medical School were published in The Journal of Experimental Medicine.

    Read More
Show More Articles